Dose-Ranging Trial Of Novavax Pandemic Flu Vaccine Demonstrates Immunogenicity
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm says further development of vaccine for Indonesia 2005 strain requires either co-development partner or government contracts.